From: DNA methylation epigenotypes in breast cancer molecular subtypes
Type | |||||
---|---|---|---|---|---|
Basal | ERBB2+ | Luminal B | Luminal A | ||
Number of patients | 59 | 49 | 54 | 53 | |
Age (years) | |||||
Mean | 56.1 | 57.1 | 56.9 | 62.9 | |
Median | 53 | 57.5 | 51 | 61 | |
Range (95% CI) | 51.5-60.7 | 52.5-61.6 | 51.8-61.7 | 56.9-68.7 | |
Tumor size (cm) | |||||
Mean | 2.4 | 2.8 | 3.2 | 3.1 | |
Range (95% CI) | 2.1-2.7 | 2.1-3.5 | 2.5-3.5 | 2.4-3.7 | |
Histologic grade (%) | |||||
I | 5.0 | 0.0 | 0.0 | 6.0 | |
II | 47.1 | 24 | 40.0 | 55.5 | |
III | 48.9 | 76 | 60.0 | 38.5 | |
Nodal involvement (%) | |||||
Positive | 35.5 | 63.4 | 72.2 | 57.3 | |
Negative | 64.4 | 36.6 | 27.8 | 42.7 | |
Ki-67 overexpression (%) | |||||
<10% | 0.0 | 8.9 | 21.9 | 27.8 | |
10%-25% | 0.0 | 36.1 | 31.2 | 66.7 | |
>25% | 100.0 | 56.0 | 46.9 | 5.6 | |
p53 mutation (%) | |||||
Positive | 47.2 | 44.1 | 21.8 | 14.8 | |
Negative | 52.8 | 55.9 | 88.2 | 85.2 |